trending Market Intelligence /marketintelligence/en/news-insights/trending/wdfuBIKqPXtUnzUM5aLdvQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

J&J recommends shareholders reject Peer & Peri's mini-tender offer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


J&J recommends shareholders reject Peer & Peri's mini-tender offer

Johnson & Johnson advised its shareholders to reject a mini-tender offer by Peer & Peri LLC as it was priced about 22.6% below-market.

Peer & Peri offered to buy up to 30,000 of the company's common shares, or about a 0.001% stake, for $98.50 per share in cash. J&J shares closed at $127.27 per share on Dec. 28, 2018, the last closing before the offer was launched.

New Brunswick, N.J.-based Johnson & Johnson, the world's largest pharmaceutical company, recommended that shareholders who have not responded to the offer to take no action, and those who tendered shares to withdraw them before the offer expires at 5 p.m. ET on Jan. 31.

Mini-tender offers involve the acquisition of less than 5% of a company's stock, allowing the buyer to avoid certain disclosure and procedural requirements of the U.S. SEC.